Minghui Pharmaceutical and ASKA Pharmaceutical have entered into an exclusive license agreement for the development and ...
DKSH Business Unit Technology, a leading market expansion services provider in Asia and beyond, and The Baker Company, a...
Researchers at Sidra Medicine, a member of Qatar Foundation, have created the Middle East’s first population-scale...
As autoimmune and allergic diseases present increasingly complex diagnostic challenges, laboratories face growing pressu...
QIAGEN has announced that its QIAsprint Connect and QIAseq FX DNA Library Kit will support automated DNA extraction and ...
Lucence is bringing its clinical genomics expertise to Singapore’s next phase of precision medicine, supporting a ...
CellProthera, a clinical-stage company developing regenerative cell therapies for ischemic diseases, has announced its s...
By Vincent Caradec, Co-Founder and CEO, Healthi Life Somewhere, this week, someone is booking a flight in the hope that...
A new Singapore study found that around one in six (16.7%) higher-risk patients with hormone receptor-positive (HR+), HE...
Merck, a leading science and technology company, has opened its new Asia-Pacific Bioprocessing Production Centre in Daej...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.06 b...
SG Austria/Austrianova, the group comprising Austrianova Singapore, Austrianova Thailand and Anovade UG, has announced t...
SG Austria/Austrianova, the group comprising Austrianova Singapore, Austrianova Thailand and Anovade UG, has announced t...
BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...
Japan-based Astellas Pharma Inc. has entered into an exclusive option and license agreement for DAX-044, Audax’s l...
Jiahui International Hospital has launched Jiahui International Cell Therapy Centre (JICC), building on landmark CAR-T c...
PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development o...
BIOPLUS-INTERPHEX KOREA 2026 opened at COEX in Seoul on Wednesday with a first day that made its priorities plain. Hoste...
Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) fi...
US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, in...
A United States (US) Government agency has selected Australia's University of Queensland (UQ) researchers to develop tec...
Moving beyond age-based breast cancer screening towards more personalised approaches to early detection and prevention i...
HighTide Therapeutics, Inc., an innovative biopharmaceutical company specializing in the development of multifunctional,...
Singapore’s biopharmaceutical industry has launched a S$4.8 million study award to strengthen its manufacturing ta...
Kaigene, Inc., a US-based biotechnology company developing antibody medicines for autoimmune diseases, has announced an ...
